Rectal prolapse secondary prevention

Jump to navigation Jump to search

Rectal prolapse Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rectal Prolapse from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Abdominal X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rectal prolapse secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rectal prolapse secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rectal prolapse secondary prevention

CDC on Rectal prolapse secondary prevention

Rectal prolapse secondary prevention in the news

Blogs on Rectal prolapse secondary prevention

Directions to Hospitals Treating Rectal prolapse

Risk calculators and risk factors for Rectal prolapse secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

Ultimate goal of treatment is to prevent progression of prolapse to incarceration or strangulation and to restore defecation function.

Secondary Prevention

Rectal incarceration and strangulation are common complications of rectal prolapse. Ultimate goal of treatment is to prevent progression of prolapse (by medical and surgical interventions), to restore defecation function, and to prevent constipation or incontinence.[1][2]

References

  1. Horster FA (1988). "[The significance of microsomal antibodies, thyroglobulin antibodies, thyrotropin receptor antibodies in the diagnosis of thyroid diseases]". Internist (Berl) (in German). 29 (8): 538–40. PMID 3053504.
  2. Chonan T, elHefnawy AM, Simonetti OP, Cherniack NS (1988). "Rate of elimination of excess CO2 in humans". Respir Physiol. 73 (3): 379–94. PMID 3140332.

Template:WH Template:WS